Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 27;43(2):113602.
doi: 10.1016/j.celrep.2023.113602. Epub 2024 Jan 17.

Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells

Affiliations

Selective induction of human renal interstitial progenitor-like cell lineages from iPSCs reveals development of mesangial and EPO-producing cells

Hiraku Tsujimoto et al. Cell Rep. .

Abstract

Recent regenerative studies using human pluripotent stem cells (hPSCs) have developed multiple kidney-lineage cells and organoids. However, to further form functional segments of the kidney, interactions of epithelial and interstitial cells are required. Here we describe a selective differentiation of renal interstitial progenitor-like cells (IPLCs) from human induced pluripotent stem cells (hiPSCs) by modifying our previous induction method for nephron progenitor cells (NPCs) and analyzing mouse embryonic interstitial progenitor cell (IPC) development. Our IPLCs combined with hiPSC-derived NPCs and nephric duct cells form nephrogenic niche- and mesangium-like structures in vitro. Furthermore, we successfully induce hiPSC-derived IPLCs to differentiate into mesangial and erythropoietin-producing cell lineages in vitro by screening differentiation-inducing factors and confirm that p38 MAPK, hypoxia, and VEGF signaling pathways are involved in the differentiation of mesangial-lineage cells. These findings indicate that our IPC-lineage induction method contributes to kidney regeneration and developmental research.

Keywords: CP: Stem cell research.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests K. Osafune is a founder and member of the scientific advisory boards of iPS Portal and a founder and chief scientific advisor of RegeNephro Co., Ltd. H.T. is an employee of RegeNephro Co., Ltd. S.-I.M. is a scientific advisor of RegeNephro Co., Ltd. T.A. is a founder and scientific advisor of RegeNephro Co., Ltd. C.G. and K.J.W. are employees of AstraZeneca plc. H.T. and K. Osafune have a patent pending for a method for producing the renal interstitial-lineage cells described in this study.

References

Publication types